Compass Gold: Follow-Up Drilling Completed at Ouassada
TORONTO, Feb. 14, 2019 (GLOBE NEWSWIRE) — Compass Gold Corp. (TSX-V: CVB) (Compass or the Company) is pleased to provide […]
SJI to Host Fiscal 2018 Year-End Earnings Conference Call
Folsom, NJ, Feb. 14, 2019 (GLOBE NEWSWIRE) — Media Contact: Marissa Travaline (609) 561-9000 [...]
Naturally Splendid to Acquire Cannabinoid Extraction Equipment from Wahupta
VANCOUVER, British Columbia, Feb. 14, 2019 (GLOBE NEWSWIRE) — NATURALLY SPLENDID ENTERPRISES LTD. (“Naturally Splendid” or “NSE”) (TSX-V:NSP)(OTCQB: NSPDF)(FRANKFURT:50N) is […]
Boise Cascade Company Fourth Quarter 2018 Earnings Webcast and Conference Call
Boise, Idaho, Feb. 14, 2019 (GLOBE NEWSWIRE) — For Immediate Release: February 14, 2019 BOISE, Idaho – Boise Cascade Company […]
Sunniva Estimates Over USD $55 Million Revenue in 2019 From Sunniva Branded Products in California and Secures Additional USD $4.0 Million in Purchase Orders
VANCOUVER, British Columbia, Feb. 14, 2019 (GLOBE NEWSWIRE) — Sunniva Inc. (“Sunniva”, the “Company”, “we”, “our” or “us”) (CSE:SNN) (OTCQB:SNNVF), […]
Orgenesis Reports 85% Increase in Revenue and 139% Increase in Gross Profit for Fiscal 2018
Expands POCare platform through a variety of valuable collaboration agreements GERMANTOWN, Md., Feb. 14, 2019 (GLOBE NEWSWIRE) — Orgenesis Inc. […]
Eloxx Pharmaceuticals to Present at the 8th Annual SVB Leerink Global Healthcare Conference in New York City on Friday, March 1, 2019
WALTHAM, Mass., Feb. 14, 2019 (GLOBE NEWSWIRE) — Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) a clinical-stage biopharmaceutical company dedicated to the […]
Toll Brothers’ Website to Broadcast its February 27, 2019 First Quarter 2019 Earnings Conference Call Live
HORSHAM, Pa., Feb. 14, 2019 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, will […]
Ultragenyx and Kyowa Kirin Announce Positive 64-Week Results for Crysvita® (burosumab) from Phase 3 Study in Children with X-linked Hypophosphatemia (XLH)
Results Confirm and Extend 40-Week Findings that Treatment with Crysvita is Superior to Conventional Therapy NOVATO, Calif., TOKYO and LONDON, […]
Sarepta Announces FDA Acceptance of Golodirsen (SRP-4053) New Drug Application for Patients with Duchenne Muscular Dystrophy Amenable to Skipping Exon 53
— FDA Grants Priority Review Status — — Regulatory Action Date is August 19, 2019 — — Golodirsen has been studied […]
